These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11678908)

  • 1. X-linked lymphoproliferative disease: three atypical cases.
    Nistala K; Gilmour KC; Cranston T; Davies EG; Goldblatt D; Gaspar HB; Jones AM
    Clin Exp Immunol; 2001 Oct; 126(1):126-30. PubMed ID: 11678908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an SH2D1A mutation in a hypogammaglobulinemic male patient with a diagnosis of common variable immunodeficiency.
    Aghamohammadi A; Kanegane H; Moein M; Farhoudi A; Pourpak Z; Movahedi M; Gharagozlou M; Zargar AA; Miyawaki T
    Int J Hematol; 2003 Jul; 78(1):45-7. PubMed ID: 12894850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome.
    Morra M; Silander O; Calpe S; Choi M; Oettgen H; Myers L; Etzioni A; Buckley R; Terhorst C
    Blood; 2001 Sep; 98(5):1321-5. PubMed ID: 11520777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression.
    Gilmour KC; Cranston T; Jones A; Davies EG; Goldblatt D; Thrasher A; Kinnon C; Nichols KE; Gaspar HB
    Eur J Immunol; 2000 Jun; 30(6):1691-7. PubMed ID: 10898506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency.
    Eastwood D; Gilmour KC; Nistala K; Meaney C; Chapel H; Sherrell Z; Webster AD; Davies EG; Jones A; Gaspar HB
    Clin Exp Immunol; 2004 Sep; 137(3):584-8. PubMed ID: 15320910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection.
    Shinozaki K; Kanegane H; Matsukura H; Sumazaki R; Tsuchida M; Makita M; Kimoto Y; Kanai R; Tsumura K; Kondoh T; Moriuchi H; Miyawaki T
    Int Immunol; 2002 Oct; 14(10):1215-23. PubMed ID: 12356686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the X-linked lymphoproliferative disease gene SH2D1A mimicking common variable immunodeficiency.
    Soresina A; Lougaris V; Giliani S; Cardinale F; Armenio L; Cattalini M; Notarangelo LD; Plebani A
    Eur J Pediatr; 2002 Dec; 161(12):656-9. PubMed ID: 12447665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
    Schuster V; Kreth HW
    Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP).
    Brandau O; Schuster V; Weiss M; Hellebrand H; Fink FM; Kreczy A; Friedrich W; Strahm B; Niemeyer C; Belohradsky BH; Meindl A
    Hum Mol Genet; 1999 Dec; 8(13):2407-13. PubMed ID: 10556288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives].
    Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive molecular diagnosis of Epstein-Barr virus-associated lymphoproliferative diseases using next-generation sequencing.
    Ono S; Nakayama M; Kanegane H; Hoshino A; Shimodera S; Shibata H; Fujino H; Fujino T; Yunomae Y; Okano T; Yamashita M; Yasumi T; Izawa K; Takagi M; Imai K; Zhang K; Marsh R; Picard C; Latour S; Ohara O; Morio T
    Int J Hematol; 2018 Sep; 108(3):319-328. PubMed ID: 29777376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.
    Sumegi J; Huang D; Lanyi A; Davis JD; Seemayer TA; Maeda A; Klein G; Seri M; Wakiguchi H; Purtilo DT; Gross TG
    Blood; 2000 Nov; 96(9):3118-25. PubMed ID: 11049992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.
    Xu T; Zhao Q; Li W; Chen X; Xue X; Chen Z; Du X; Bai X; Zhao Q; Zhou L; Tang X; Yang X; Kanegane H; Zhao X
    Eur J Pediatr; 2020 Feb; 179(2):327-338. PubMed ID: 31754776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses.
    Sumazaki R; Kanegane H; Osaki M; Fukushima T; Tsuchida M; Matsukura H; Shinozaki K; Kimura H; Matsui A; Miyawaki T
    Blood; 2001 Aug; 98(4):1268-70. PubMed ID: 11493483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.
    Jin YY; Zhou W; Tian ZQ; Chen TX
    Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
    Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
    Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
    Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
    Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia].
    Li WY; Chen JS; Zhao Q; Dai RX; Wang YP; Zhao HY; Chen XM; Xue XH; Sun XY; Tang XM; Zhang Y; Ding Y; Zhao XD; Zhang ZY
    Zhonghua Er Ke Za Zhi; 2017 May; 55(5):377-382. PubMed ID: 28482391
    [No Abstract]   [Full Text] [Related]  

  • 19. SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients.
    Yin L; Ferrand V; Lavoué MF; Hayoz D; Philippe N; Souillet G; Seri M; Giacchino R; Castagnola E; Hodgson S; Sylla BS; Romeo G
    Hum Genet; 1999 Nov; 105(5):501-5. PubMed ID: 10598819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.
    Palendira U; Low C; Chan A; Hislop AD; Ho E; Phan TG; Deenick E; Cook MC; Riminton DS; Choo S; Loh R; Alvaro F; Booth C; Gaspar HB; Moretta A; Khanna R; Rickinson AB; Tangye SG
    PLoS Biol; 2011 Nov; 9(11):e1001187. PubMed ID: 22069374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.